LINDAHL GUNNAR has a total of 19 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are ICM CO LTD, EPITOPIX LLC and EMERY DARYLL A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | South Africa | 2 | |
#7 | United Kingdom | 1 | |
#8 | Hong Kong | 1 | |
#9 | New Zealand | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Unspecified technologies | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Lindahl Gunnar | 17 |
#2 | Stalhammar-Carlemalm Margareth | 15 |
#3 | Stenberg Lars | 10 |
#4 | Areschoug Thomas | 5 |
#5 | Larsson Charlotte | 5 |
#6 | St Lhammar-Carlemalm Margareth | 1 |
#7 | Staalhammar-Carlemalm Margaret | 1 |
#8 | Stenber Lars | 1 |
Publication | Filing date | Title |
---|---|---|
GB9910375D0 | Vaccine composition | |
US6015889A | Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition | |
ZA941958B | Protein rib,a cell surface protein that confers immunity to many strains of the group B steptococcus process for purification of the protein reagent kit and pharmaceutical composition |